FDA Adverse Event
Injury
Summary report: N
MUGARD ORAL RINSE 240ML/BTL
MDR report key: 23771605
·
Received December 10, 2025
Report
- Report Number
- MW5180285
- Event Type
- Injury
- Date Received
- December 10, 2025
- Report Date
- December 5, 2025
- Manufacturer
- SOLEVA PHARMA LLC
- Product Code
- OLR
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
Description of Event or Problem · 0
EVENT: CAREGIVER REPORTED THAT THE PATIENT IS IN THE HOSPITAL FOR DIARRHEA AND DEHYDRATION, UNSURE IF PATIENT IS NEW TO THERAPY OR NOT, THIS IS THEIR FIRST FILL WITH WSP. FREQ: RINSE MOUTH WITH 5-10ML FOR AT LEAST ONE MINUTE 4 TIMES A DAY. EXPEL QR SWALLOW AFTER RINSING. AVOID EATING QR DRINKING FOR AT LEAST 1 HOUR AFTER USE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2554714 | MUGARD ORAL RINSE 240ML/BTL | ORAL WOUND DRESSING | OLR | SOLEVA PHARMA LLC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female |